Replacement Director/PDMR Shareholding

RNS Number : 7652X

GlaxoSmithKline PLC

15 January 2014

 



This announcement replaces the original announcement released on 3 January 2014 at 9.43am (RNS No: 8550W).

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).

On 31 December 2013, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2013; calculated using an average price of £16.073 per Ordinary Share and $53.170 per ADS:

Non-Executive Director	Ordinary Shares	No. of ADSs
Sir Christopher Gent	4,466.364
Prof Sir Roy Anderson	685.862
Dr Stephanie Burns		538.531
Stacey Cartwright	125.504
Lynn Elsenhans		78.145
Judy Lewent		80.720
Sir Deryck Maughan		1,379.853
Dr Daniel Podolsky		968.774
Tom de Swaan	998.268
Jing Ulrich		24.625
Hans Wijers	3.630
Sir Robert Wilson	1,032.435

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

Sonja Arsenić 

Corporate Secretariat

15 January 2014

 

END

 

 

RDSDMGMMVKKGDZM